Abbvie Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 03, 2020 / 04:00PM GMT
Christopher Joseph Raymond - Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Great. Well, thanks, everybody, for joining us for our next session. Very pleased to have with us our next presenter, which is AbbVie. We have with us Mike Severino, who is the Vice Chairman and President; and also Rob Michael. My name is Chris Raymond. I'm one of Piper Sandler's biotech analyst. So a lot to unpack, a lot going on at AbbVie.

For folks who are unaware of our format, this is a virtual fireside chat. And what I would urge folks to do is there's an option to ask questions via the Zoom link that I think everybody has dialed into. If you don't want to do that, just tip me up on e-mail. I'll make sure your question gets asked and answered.

So before we dive into questions, I think what we'll do is have Mike give a quick overview, maybe 1 or 2 minutes, just to level set the story for investors, and then we'll dive into Q&A. So Mike, please take it away.

Michael E. Severino - AbbVie Inc. - Vice Chairman & President

Thanks,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot